Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin Americans.

BACKGROUND Information on actual sodium intake and its relationships with blood pressure (BP) and clinical events in South America is limited. The aim of this cohort study was to assess the relationship of sodium intake with BP, cardiovascular (CV) events, and mortality in South America. METHODS We studied 17,033 individuals, aged 35-70 years, from 4 South American countries (Argentina, Brazil, Chile, and Colombia). Measures of sodium excretion, estimated from morning fasting urine, were used as a surrogate for daily sodium intake. We measured BP and monitored the composite outcome of death and major CV events. RESULTS Overall mean sodium excretion was 4.70±1.43g/day. A positive, nonuniform association between sodium and BP was detected, with a significant steeper slope for the relationship at higher sodium excretion levels (P < 0.001 for interaction). With a median follow-up of 4.7 years, the primary composite outcome (all-cause death, myocardial infarction, stroke, or heart failure) occurred in 568 participants (3.4%). Compared with sodium excretion of 5-6g/day (reference group), participants who excreted >7g/day had increased risks of the primary outcome (odds ratio (OR) 1.73; 95% confidence interval (CI) 1.24 to 2.40; P < 0.001), as well as death from any cause (OR 1.87; 95% CI 1.23 to 2.83; P = 0.003) and major CV disease (OR 1.77; 95% CI 1.12 to 2.81; P = 0.014). Sodium excretion of <3g/day was associated with a statistically nonsignificant increased risk of the primary outcome (OR 1.20; 95% CI 0.86 to 1.65; P = 0.26) and death from any cause (OR 1.25; 95% CI 0.81 to 1.93; P = 0.29), and a significant increased risk of major CV disease (OR 1.50; 95% CI 1.01 to 2.24; P = 0.048), as compared to the reference group. CONCLUSIONS Our results support a positive, nonuniform association between estimated urinary sodium excretion and BP, and a possible J-shaped pattern of association between sodium excretion over the entire range and clinical outcomes.

[1]  W. Elliott.  Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion , 2012 .

[2]  K. Itoh,et al.  A SIMPLE METHOD FOR ESTIMATING 24 H URINARY SODIUM AND POTASSIUM EXCRETION FROM SECOND MORNING VOIDING URINE SPECIMEN IN ADULTS , 1993, Clinical and experimental pharmacology & physiology.

[3]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[4]  S. Yusuf,et al.  Urinary sodium and potassium excretion, mortality, and cardiovascular events. , 2014, The New England journal of medicine.

[5]  S. Yusuf,et al.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.

[6]  G. Jürgens,et al.  The significance of duration and amount of sodium reduction intervention in normotensive and hypertensive individuals: a meta-analysis. , 2015, Advances in nutrition.

[7]  G. Jürgens,et al.  Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. , 2014, American Journal of Hypertension.

[8]  D. Gordin,et al.  The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes , 2011, Diabetes Care.

[9]  Salim Yusuf,et al.  The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. , 2009, American heart journal.

[10]  S. Ferreira,et al.  Estimativa de consumo de sdio pela populao brasileira, 2002-2003 , 2009 .

[11]  G. MacGregor,et al.  Effect of longer-term modest salt reduction on blood pressure. , 2000, The Cochrane database of systematic reviews.

[12]  Peilin Shi,et al.  Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment , 2015, The Lancet. Global health.

[13]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[14]  A. Zanchetti,et al.  Latin American guidelines on hypertension. Latin American Expert Group. , 2009, Journal of hypertension.

[15]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.

[16]  Orton,et al.  EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .

[17]  Sociedade Brasileira de Nefrologia,et al.  [VI Brazilian Guidelines on Hypertension]. , 2010, Arquivos brasileiros de cardiologia.

[18]  S. Sharp,et al.  Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC‐Norfolk study , 2014, European journal of heart failure.

[19]  Merlin C. Thomas,et al.  Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes , 2011, Diabetes Care.

[20]  A. Rodgers,et al.  Global burden of blood-pressure-related disease, 2001 , 2008, The Lancet.

[21]  S. Yusuf,et al.  Urinary sodium and potassium excretion and risk of cardiovascular events. , 2011, JAMA.

[22]  G. Scally.  Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. , 1988, BMJ.

[23]  P. López-Jaramillo,et al.  [Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome]. , 2014, Arquivos brasileiros de endocrinologia e metabologia.

[24]  S. Yusuf,et al.  Association of urinary sodium and potassium excretion with blood pressure. , 2014, The New England journal of medicine.

[25]  W. Elliott.  Global burden of blood-pressure-related disease, 2001 , 2009 .

[26]  Martin McKee,et al.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. , 2013, JAMA.

[27]  R. Wilks,et al.  PAHO/WHO regional expert group policy statement – preventing cardiovascular disease in the Americas by reducing dietary salt intake population-wide , 2009 .

[28]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[29]  H. Schargrodsky,et al.  Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study , 2010, Journal of hypertension.

[30]  Jeremiah Stamler,et al.  Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. , 1988 .

[31]  S. Yusuf,et al.  Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries , 2014, Journal of hypertension.

[32]  R. Levy,et al.  [Estimated sodium intake by the Brazilian population, 2002-2003]. , 2009, Revista de saude publica.